A randomized double blind, placebo controlled study of risperidone in the treatment of DSM-IV-TR conduct disorder in children and adolescents
Phase of Trial: Phase III
Latest Information Update: 09 Aug 2017
At a glance
- Drugs Risperidone (Primary)
- Indications Conduct disorder
- Focus Therapeutic Use
- Acronyms CONCA
- 16 Apr 2014 New source identified and integrated (United Kingdom Clinical Research Network: 13994).
- 20 Oct 2012 New source identified and integrated (European Clinical Trials Database record: EudraCT2011-000567-26).
- 23 Apr 2012 New trial record